Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IWO vs VHT: how they differ
IWO and VHT hold 5% of their weight in the same names, and VHT returned more over the year.
iShares Russell 2000 Growth ETF and Vanguard Health Care Index Fund.
What they hold in common
By the books each fund has filed, IWO and VHT hold 5% of their money in the same securities at the same weight.
| Holding | IWO | VHT |
|---|---|---|
| BrightSpring Health Services, Inc. | 0.68% | 0.14% |
| Praxis Precision Medicines, Inc. | 0.51% | 0.13% |
| HealthEquity, Inc. | 0.46% | 0.12% |
| Krystal Biotech, Inc. | 0.58% | 0.11% |
| Lantheus Holdings, Inc. | 0.43% | 0.10% |
| Vaxcyte, Inc. | 0.30% | 0.10% |
| Glaukos Corp. | 0.48% | 0.09% |
| TG Therapeutics, Inc. | 0.48% | 0.09% |
| PTC Therapeutics, Inc. | 0.35% | 0.08% |
| Hims & Hers Health, Inc. | 0.45% | 0.08% |
| Protagonist Therapeutics, Inc. | 0.45% | 0.08% |
| Rhythm Pharmaceuticals, Inc. | 0.37% | 0.08% |
| Only in IWO | Only in VHT |
|---|---|
| Moog, Inc. 0.73% | Eli Lilly & Co 14.07% |
| MaxLinear, Inc. 0.67% | Johnson & Johnson 8.48% |
| Argan, Inc. 0.66% | AbbVie Inc 6.10% |
| JFrog Ltd. 0.60% | UnitedHealth Group Inc 5.46% |
| ESCO Technologies, Inc. 0.56% | Merck & Co Inc 4.67% |
| FirstCash Holdings, Inc. 0.54% | Thermo Fisher Scientific Inc 2.93% |
| D-Wave Quantum, Inc. 0.53% | Amgen Inc 2.87% |
| StoneX Group, Inc. 0.52% | Gilead Sciences Inc 2.64% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
| IWO iShares Russell 2000 Growth ETF | VHT Vanguard Health Care Index Fund | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | Vanguard |
| What it is | Russell 2000 Growth | Health Care |
| Total return, 1 year | +17.0% | +21.6% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −0.5 pts | +4.1 pts |
| Expense ratio | 0.24% | 0.09% |
| Already in the S&P 500 | 0.0% | 85.6% |
| Holdings | 1133 | 401 |
IWO in plain words
IWO is an index equity fund tracking the Russell 2000 Growth. Over the year to Sep 11, 2026 it returned +17.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.24% a year. By its holdings filed for Jun 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 1133 positions, with the top ten at 6.1%. It sat 7.1% below its high of Aug 14, 2026 on Sep 11, 2026.
VHT in plain words
VHT is an index equity fund tracking the Health Care. Over the year to Sep 11, 2026 it returned +21.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.09% a year. By its holdings filed for May 31, 2026, 86% of the fund by weight is stocks the S&P 500 also holds, across 401 positions, with the top ten at 52.0%. It sat 5.7% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, IWO or VHT?
- In the year to Sep 12, 2026, with distributions reinvested, IWO returned +17.0% and VHT returned +21.6%, so VHT returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IWO or VHT?
- IWO charges 0.24% a year and VHT charges 0.09%, so VHT is cheaper. Fees come from each fund's prospectus.
- How much do IWO and VHT overlap with the S&P 500?
- By their latest filed holdings, 0% of IWO and 86% of VHT by weight is stocks the S&P 500 already holds. Between the two funds, 5% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IWO against VHT, data as of Sep 12, 2026. https://etfiq.com/compare/any/IWO-VHT Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources